Article It's no secret that Reliq probably paid for this article to get out there. But it was with good reason - to attract new investors as well as promote their progress, shine some light on exciting things to come as well as show that they have completely turned things around since last years mess. I'm not sure about you guys but it summarizes everything I've researched the last couple months that has led to me adding to postion recently. Unless this is all a sick joke and I'm a god dam fool I think Reliq are gonna start knocking it out of the park.
I've been long on this company for a couple years now and I'm currently sitting close to what my original entry point was years ago but it's really hard to not get excited about what's coming for this company if they execute correctly, the stock reached $2.40 a few years ago all on speculation of what was coming, now there is even more positive developments since then regarding their target market. Biggest one I picked up in the last webinar was Lisa's comment regarding Medicare and Madicaid billing codes for RPM expanding the potential market from 20 million to 80 million - summarized in this section in the article pasted below.
Either way, I understand the market has some trust issues with what has happened in the past and the the bottom line has not lied in recent financial statements but I think we are finally past what has happened and we are finally getting what we were promised with this company years ago. I really hope I'm not here giving my head a shake here in 6 months with how they did not deliver again hah but I think this company is getting ready to take off. Good luck to everyone.
" Up until 2019, remote patient monitoring (RPM) was covered by Medicaid, but only in 21 states, and could only be billed by physicians. As of this year, however, CMS is allowing home health agencies to bill Medicaid directly to increase utilization of RPM, and Medicare now covers RPM for its patients. In addition, CMS expanded the billing codes for RPM, more than doubling the potential reimbursement for providers by adding coverage for initial setup and training, patient education, device/transmission fees and other services. These changes expand the potential market for Reliq in the RPM space from less than 20 million patients to over 80 million patients, with the coverage for additional services dramatically increasing the market pull for Reliq's services"